Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 1c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($0.88), $0.01 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $3.03 million versus the consensus estimate of $13.65 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight